Synlogic Inc · OTC:SYBX
Synlogic — Q1 2019 Earnings Presentation
7 slides from Synlogic's earnings presentation, May 9, 2019
Slide 1: 1Q2019 Teleconference
Synlogic DESIGNED FOR LIFE 1Q2019 Teleconference May 9, 2019
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in
Slide 3: Demonstrated Progress in Development of Lyophilized SYNB1618
Demonstrated Progress in Development of Lyophilized SYNB1618 Improved fermentation process enables production of a solid formulation of SYNB1618 with minimal impact on cell viability or activityLyophilized SYNB1618 is similarly active to frozen liquid in terms of consumption of Phe or production of
Slide 4: Batch to Batch Consistency of SYNB1618 Solid Formulation
Batch to Batch Consistency of SYNB1618 Solid Formulation Viability Activity in WT mice
Slide 5: Stability of SYNB1618 Solid Formulation
Stability of SYNB1618 Solid Formulation
Slide 6: 2019 Progress and Milestones
2019 Progress and Milestones SYNB1618 in PKUComplete ongoing study in patientsData expected 3Q2019 (safety, tolerability and biomarkers)SYNB1020 in HyperammonemiaPreclin. and HV clin. data published in Sci. Transl. Med.Complete ongoing study in patients with cirrhosisData expected 3Q2019 (safety, to
Slide 7: BINNEY ST., #402, CAMBRIDGE, MA 02142TEL: 617-401-9975WEB: WWW.SYNLOGICTX.COM | EMAIL: INFO@SYNLOGICTX.COM© SYNLOGIC.…
301 BINNEY ST., #402, CAMBRIDGE, MA 02142TEL: 617-401-9975WEB: WWW.SYNLOGICTX.COM | EMAIL: INFO@SYNLOGICTX.COM© SYNLOGIC. CONFIDENTIAL. ALL RIGHTS RESERVED.